Evidence map›Paper›PMID 36510010›Full record

ArticleNature cancer2022

Two isoleucyl tRNAs that decode synonymous codons divergently regulate breast cancer metastatic growth by controlling translation of proliferation-regulating genes.

Lisa B Earnest-Noble, Dennis Hsu, Siyu Chen, Hosseinali Asgharian, Mandayam Nandan, Maria C Passarelli, Hani Goodarzi, Sohail F Tavazoie

Open access · greenAbstract read
In one paragraph

Article in Nature cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.5field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. The regulation, function and disease relevance of cytoplasmic tRNAs.Nature reviews. Molecular cell biology · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Cell type-specific purifying selection of synonymous mitochondrial DNA variation.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. ELAC2 is a functional prostate cancer risk allele.Trends in molecular medicine · 2023
    Article
  20. Metastasis.Cell · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Lisa B Earnest-NobleLaboratory of Systems Cancer Biology, The Rockefeller University, New York, NY, USA.
Dennis HsuLaboratory of Systems Cancer Biology, The Rockefeller University, New York, NY, USA.ORCID http://orcid.org/0000-0003-4200-1098
Siyu ChenDepartment of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, CA, USA.
Hosseinali AsgharianDepartment of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, CA, USA.
Mandayam NandanLaboratory of Systems Cancer Biology, The Rockefeller University, New York, NY, USA.
Maria C PassarelliLaboratory of Systems Cancer Biology, The Rockefeller University, New York, NY, USA.ORCID http://orcid.org/0000-0002-5749-5425
Hani GoodarziDepartment of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, CA, USA. hani.goodarzi@ucsf.edu.ORCID http://orcid.org/0000-0002-9648-8949
Sohail F TavazoieLaboratory of Systems Cancer Biology, The Rockefeller University, New York, NY, USA. sohail.tavazoie@rockefeller.edu.ORCID http://orcid.org/0000-0002-4966-9018
Rockefeller University · USUniversity of California, San Francisco · US

Funding

Weill Cornell/Rockefeller/Sloan-Kettering MST ProgramT32GM007739 · NIGMS · WEILL MEDICAL COLL OF CORNELL UNIV · PI HSU, KATHARINE C · 1985 to 2023
$51.1M
Single-Cell & Computational Biology CoreU54CA261701 · NCI · ROCKEFELLER UNIVERSITY · PI Sohail F. Tavazoie · 2021 to 2026
$9.1M
CLINICAL SCHOLARS BIOMEDICAL RESEARCH TRAINING PROGRAMT32CA009512 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Ping Chi · 1985 to 2026
$6.3M
Biology and genetics of metastatic diseaseR35CA274446 · NCI · ROCKEFELLER UNIVERSITY · PI Sohail F. Tavazoie · 2022 to 2026
$4.7M
Molecular Mechanisms underlying tRNA-fragment regulation of cancerR01CA215491 · NCI · ROCKEFELLER UNIVERSITY · PI TAVAZOIE, SOHAIL F. · 2017 to 2021
$2.3M
Regulation of metastatic progression by an endothelial-derived factorR01CA236954 · NCI · ROCKEFELLER UNIVERSITY · PI TAVAZOIE, SOHAIL F. · 2019 to 2022
$1.9M
Systematic dissection of an aberrant splicing program driving cancer metastasisR00CA194077 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GOODARZI, HANI · 2016 to 2018
$746k
Howard Hughes Medical InstituteNCI NIH HHS R00 CA194077NCI NIH HHS R01 CA215491NCI NIH HHS R01 CA236954NCI NIH HHS R35 CA274446NCI NIH HHS T32 CA009512NCI NIH HHS U54 CA261701NIGMS NIH HHS T32 GM007739
6 · The paper itself

Abstract

The human genome contains 61 codons encoding 20 amino acids. Synonymous codons representing a given amino acid are decoded by a set of transfer RNAs (tRNAs) called isoacceptors. We report the surprising observation that two isoacceptor tRNAs that decode synonymous codons become modulated in opposing directions during breast cancer progression. Specifically, tRNA

Indexed as

Breast NeoplasmsAmino AcidsAnimalsCell ProliferationCodonFemaleHumansMiceRNA, TransferRNA, Transfer, IleAmino AcidsCodonRNA, TransferRNA, Transfer, Ile

Identifiers

PMID36510010
PMCPMC11323107
OpenAlexW4312132219

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.